The most significant FDA approvals of the decade (2010-2019)

From innovative leaps in cancer diagnosis and treatment to the growing force of artificial intelligence in aiding medical discovery, the 2010s was a ground-breaking decade for the life science industry. We have seen the steady rise of targeted and personalised medicines, and advancements in genetic engineering have thrown up controversial yet undeniably ground-breaking potential that could completely change the way we diagnose and treat disease in the future.

To bring these incredible drug breakthroughs to US patients, the Food & Drug Association (FDA) approved a significant number of innovative drugs and therapies between 2010-2019. 2017 was a record-breaking year – with the FDA approving 55 drugs, and in 2019, there was still an impressive 48 innovative medicines approved.

Enabling Stable and Directly Compressible Probiotic Tablet Formulations with a Novel Co-processed Mannitol-Starch Excipient

Development of novel portable NIR spectroscopy process analytical technology (PAT) tool for monitoring the transition of ibuprofen to ibuprofen sodium during wet granulation process

Enhancing breast cancer treatment: Comprehensive study of gefitinib-loaded poloxamer 407/TPGS mixed micelles through design, development, in-silico modelling, In-Vitro testing, and Ex-Vivo…

Many of these medicines were approved by other industry bodies elsewhere in the world, such as the European Medicines Agency (EMA) and China’s National Medical Products Administration (NMPA) increasing the accessibility of these new, life saving treatments to patients globally.

The last decade has been truly outstanding for … continue the article by Peter Hogg